Press Releases
REDWOOD CITY, Calif., Oct. 22, 2019 /PRNewswire/ -- Revolution Medicines, Inc., a clinical-stage oncology company focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways, today announced that preclinical in vivo data on the company's novel inhibitors of oncogenic RAS(ON) mutan
Read more...SAN FRANCISCO, Oct. 22, 2019 /PRNewswire/ -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today announced that promising preclinical data from two of its gene therapy-focused subsidiaries – Adrenas Therapeutics and Aspa Therapeutics – will be presented at the European Society of Gene and Cell Therapy (ESGCT) Conference, occurring in Ba
Read more...22 October 2019
TAMPA, Florida, Oct. 22, 2019 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative treatments based on the Company's proprietary NK cell engager (TriKE™) platform, announced today that Drs. Jeffrey Miller, Martin Felices and P
Read more...22 October 2019
HOUSTON, Oct. 22, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced the expansion of Annamycin production commitments in response to management's assessment of positive AML clinical trial acti
Read more...22 October 2019
MENLO PARK, Calif., Oct. 22, 2019 /PRNewswire/ -- Sight Sciences, Inc., today announced a new, single center study of glaucoma surgery patients published in the July 2019 issue of Clinical Ophthalmology, which shows that ab-interno microcatheterization and 360˚ viscodilation of Schlemm's Canal using one of the OMNI® Surg
Read more...CARLSBAD, Calif., Oct. 22, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Wednesday, November 6th at 11:30 a.m. Eastern Time to discuss its third quarter 2019 financial results and report on pipeline and business progress.
Read more...--- Shipments to commence in December from the Company's Mississauga, Ontario facility TORONTO, Oct. 22, 2019 /PRNewswire/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada
Read more...REDWOOD CITY, Calif., Oct. 22, 2019 /PRNewswire/ -- Synthego, the leading genome engineering company, today announced the launch of genome engineering for induced pluripotent stem (iPS
Read more...22 October 2019
DALLAS, Oct. 22, 2019 /PRNewswire/ -- HealthMine, the health action engagement company, announced Amy Lung has been appointed Chief Operating Officer. Lung is an expert in driving quality improvement through data-driven member and provider engagement strategies. She has extensive experience working between health plans and provider org
Read more...OLDWICK, N.J., Oct. 22, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced top-line results from its randomized, placebo-controlled Phase 2a PRINCE clinical trial evaluating twice-daily PRV-6527, an oral Colony Stimulating Factor-1 Receptor
Read more...